by PharmacyChecker.com | Oct 11, 2010 | Drug Prices, Healthcare Reform, Medicare Drug Plans
With open enrollment for Medicare Part D just around the corner, 50% discounts on brand name prescriptions while in the coverage gap seems to be a great new benefit this coming year… or is it? Some patient advocate groups, and we at PharmacyChecker.com, are asking, 50% off what price? Will PhRMA offer the discount on a higher-than-normal base price to cover their losses?
As the market, not the government, controls drug prices, it is a possibility that manufacturers will up the prices on drugs, especially specialty medications that lack brand-name alternative or generic competition, in order to make up for the lost profit. A brand name drug that costs $100 per month now – $50 in 2011 for Medicare Part D enrollees – may likely cost $120 next year – or $60 for Medicare enrollees – so that the manufacturers are able to spare revenue loss little by little. (more…)
Tagged with: affordable prescriptions, Drug Prices, health, Healthcare Reform, Medicare, Medicare Drug Plans, Part D, phrma, save money, seniors, United States
by Gabriel Levitt, Vice President, PharmacyChecker.com and Margaret Rode, PharmacyChecker.com | Aug 27, 2010 | Drug Prices
AARP, the leading advocacy group for America’s seniors, released a new study confirming that brand name drug prices were way up – 8.3 % higher on average – in 2009. These large increases occurred during a year when the consumer price index was actually down by .4% . The report also finds that over the past five years, brand-name drug costs have increased by 41.5%, during which inflation only rose by 13%. Noteworthy in this report is that its authors, responding to pharmaceutical industry critics who contested that prior AARP reports only looked at manufacturer prices, derived the current findings by calculating the average retail prices of over 200 popular brand name drugs.
(more…)
Tagged with: AARP, Drug Prices, health, pharmacychecker.com, phrma
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Jun 2, 2010 | Politics
Senator Byron Dorgan (D-SD), who is leaving congress at the end of this term, continues to stand up to the pharmaceutical industry and on behalf of American consumers, as he is once again trying to push forward legislation that legalizes drug importation in a manner that could make prescription medication more affordable. In December of 2009, Dorgan introduced an amendment to H.R. 3590: Patient Protection and Affordable Care Act to legalize drug importation, which received 51 yeas and 48 nays, falling short of the 60 votes needed for passage. Now Dorgan plans to introduce his legislation as an amendment to the food safety bill, which is sponsored by John Dingell (D-Mich). Dingell, however, is an adamant opponent to drug importation and is against attaching the amendment to his bill. Read the details in The Hill.
(more…)
Tagged with: Dorgan, Drug Prices, Healthcare Reform, Online Pharmacies, personal drug importation, pharmaceutical companies, phrma, policy
